Oppenheimer analysts initates an Outperform rating for Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Inc’s filing revealed that its Director Booth Bruce unloaded Company’s shares for reported $2.9 million on Mar 15
Kymera Therapeutics Inc’s filing revealed that its Director Booth Bruce unloaded Company’s shares for reported $2.9 million on Mar 15
Kymera Therapeutics Inc’s recently made public that its Director Booth Bruce unloaded Company’s shares for reported $2.9 million on Mar
Kymera Therapeutics Inc’s recent filing unveils that its Director Booth Bruce unloaded Company’s shares for reported $2.9 million on Mar
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Kymera Therapeutics
Kymera Therapeutics Inc’s recent filing unveils that its Director Booth Bruce unloaded Company’s shares for reported $2.9 million on Mar
Kymera Therapeutics Inc’s filing revealed that its Director Booth Bruce unloaded Company’s shares for reported $2.9 million on Mar 15